According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected to grow at a CAGR of 17% from 2025 to 2034. Check out this article for product trends and more.
- The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
- The Technologies Propelling GLP-1 Analogues
- Are CDMO Partnerships The Answer To Manufacturing Capacity Issues?
- Combination Products: U.S. Vs. EU Requirements And A Harmonized Strategy To Prepare CTD Module 3
- Addressing Challenges In Automated Visual Inspection Of Lyophilized Vials
- Subcutaneous Self-Administration: 3 Key Market Drivers, 3 Key Delivery Challenges
- Growth And Advancements In Transdermal Drug Delivery
- Comparison Of WFI Production Methods: Multi-Effect Distillation Vs. Vapor Compression
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why 'Off-The-Shelf' Devices Do Not Circumvent Design Controls
Utilizing off-the-shelf (OTS) devices for drug delivery can offer significant advantages to development programs in timeline and risk mitigation. Understand the design control responsibilities of a sponsor when using OTS devices.
-
A Practical Packaging Components Checklist For Emerging Biotechs
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Pediatric Dosage Form Development: Program Design And Formulation Development
Explore key considerations to successfully bridge from initial concept of pediatric program design and formulation development strategies into later stages of development and through to commercialization.
-
A Step Change In Pharmaceutical Glass Packaging Innovation
Valor Glass represents a significant, and much needed, step forward for glass innovation. Review the findings and learn how an aluminosilicate formulation can lower your glass vials' extractables profile.
-
Developing An Effective Lipid Nanoparticle Formulation Process For Small Molecule And Biologicals Delivery
Lipid nanoparticles (LNPs) are a versatile formulation technology used by drug development teams to deliver a variety of small/large molecules, peptides, and biologicals.
-
Recent Innovations And Enhancements To Pharmaceutical Spray Drying
Finding alternative solvent approaches could allow for lower volumes of less toxic solvents, significantly improving both the environmental and human health implications of new drugs produced.
-
De-Risking Visible Particles Through Component Selection
Explore a summary of the FDA’s recent draft guidance “Inspection of Injectable Products for Visible Particulates” and how it applies to components.
-
Delivering The Promise Of Gene Therapy
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
Capsule Formulation Development: From Dosage Forms To Filling
Capsules are tasteless and easy to take, offer streamlined development timelines, and simplicity of manufacturing. Discover capsule formulation development and the benefits of capsule dosage forms.
-
Overcoming A Failed Design Verification Test For Your Delivery Device
If a drug delivery device fails a design verification test, the consequences can be lost revenue for the pharma company and delays for patients. Explore how to eliminate design verification failure.
Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
FRANKLY FRAN
-
In this article, Fran DeGrazio underscores the importance of design controls in the development of combination products and other drug delivery devices. She explains foundational concepts and fundamental steps including design inputs and outputs, design verification and validation, design review, and change controls.
- Subcutaneous Self-Administration: 3 Key Market Drivers, 3 Key Delivery Challenges
- Use-Related Risk Analysis: Considering The FDA Guidance On URRA
- Drug Delivery Outlook: 7 Waves To Ride In 2025 And Beyond
- 5 Top-Of-Mind Drug Delivery Topics In 2024
- Understanding Essential Drug Delivery Outputs: Things To Know About EDDOs
- 5 Keys to Supplier/Purchasing Controls – And Product Quality
- Preparing For The FDA QMSR: Will You Be Ready?
- Setting The Bar For Drug Product Quality, Part 2: The Evolving Practice Of Particle Testing
- Setting The Bar For Drug Product Quality, Part 1: How Best Practices Prevail